Literature DB >> 31895612

The Case for Maintenance Pemetrexed Plus Bevacizumab.

Nasser Hanna1, Shadia Jalal1.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 31895612     DOI: 10.1200/JCO.19.02348

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Reply to N. Hanna et al and L. Xie et al.

Authors:  Suresh S Ramalingam; Suzanne E Dahlberg
Journal:  J Clin Oncol       Date:  2020-01-02       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.